Cargando…
Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition
Autores principales: | Chowers, Guy, Abebe-Campino, Gadi, Golan, Hana, Vivante, Asaf, Greenberger, Shoshana, Soudack, Michalle, Barkai, Galia, Fox-Fisher, Ilana, Li, Dong, March, Michael, Battig, Mark R., Hakonarson, Hakon, Adams, Denise, Dori, Yoav, Dagan, Adi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440952/ https://www.ncbi.nlm.nih.gov/pubmed/35246606 http://dx.doi.org/10.1038/s41390-022-01986-0 |
Ejemplares similares
-
Kaposiform lymphangiomatosis effectively treated with MEK inhibition
por: Foster, Jessica B, et al.
Publicado: (2020) -
A Somatic Activating NRAS Variant Associated with Kaposiform Lymphangiomatosis
por: Barclay, Sarah F., et al.
Publicado: (2018) -
Kaposiform lymphangiomatosis and kaposiform hemangioendothelioma: similarities and differences
por: Ji, Yi, et al.
Publicado: (2019) -
Sirolimus in the treatment of kaposiform lymphangiomatosis
por: Zhou, Jiangyuan, et al.
Publicado: (2021) -
Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis
por: Ozeki, Michio, et al.
Publicado: (2019)